Skip to main content

Mega diabetes drug to be cheaper soon

With one of the relatively newer but important anti-diabetic drugs, Vildagliptin manufactured by Novartis, losing patent protection in December, dozens of companies are readying plans to launch the generic version to get a slice of the action in the growing Rs 13,000-crore diabetes therapy. The cost of therapy is expected to reduce by over 50%.

from India News | Latest News Headlines & Live Updates from India - Times of India https://ift.tt/30VklKU
Labels:

Comments

Post a Comment

Thank You for your comment, our moderation team check your comments if it is not spam then publish.

Popular posts from this blog

2020: The Year in Visual Stories and Graphics

By Unknown Author from NYT U.S. https://ift.tt/3pCtFQ5
Post a Comment
Read more

India sees record 10.6L tests in a day, total crosses 4cr

The exponential jump in testing capacity and the number of tests have resulted in an upsurge in tests per million to 30,044, the health ministry said, underlining the role of aggressive testing in early identification of positive cases and their contacts. from India News | Latest News Headlines & Live Updates from India - Times of India https://ift.tt/3hJrc2D
Post a Comment
Read more